发布求助
文献互助 智能选刊 最新文献

Immuno-oncology technology最新文献

筛选
英文 中文
70P Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small cell lung cancer PD-1阻断加化疗对癌源性非小细胞肺癌患者的疗效
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100813
H. Wang , L. Cheng , Q. Wang , C. Zhou
{"title":"70P Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small cell lung cancer","authors":"H. Wang , L. Cheng , Q. Wang , C. Zhou","doi":"10.1016/j.iotech.2024.100813","DOIUrl":"10.1016/j.iotech.2024.100813","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100813"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143127802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
71P Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients: A systematic review and meta-analysis 非疾病进展原因停用免疫检查点抑制剂以及对晚期黑色素瘤患者复发和生存的影响：一项系统综述和荟萃分析
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100814
K. Lallas , E. Chatziioannou , D. Durak , G. Frey , L.M. Serna Higuita , M-L. Rasch , A. Kyrgidis , Z. Apalla , U. Leiter-Stoppke , L. Flatz , A. Lallas , T.M.S. Amaral
{"title":"71P Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients: A systematic review and meta-analysis","authors":"K. Lallas , E. Chatziioannou , D. Durak , G. Frey , L.M. Serna Higuita , M-L. Rasch , A. Kyrgidis , Z. Apalla , U. Leiter-Stoppke , L. Flatz , A. Lallas , T.M.S. Amaral","doi":"10.1016/j.iotech.2024.100814","DOIUrl":"10.1016/j.iotech.2024.100814","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100814"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143127803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
60P Innovative applications of neoantigens in dendritic cell-derived exosome (DEX) therapy and their impact on personalized cancer treatment 新抗原在树突状细胞衍生外泌体（DEX）治疗中的创新应用及其对癌症个性化治疗的影响
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100871
R.E. Gutierrez , F. Gutierrez Castro , I. Rivadeneira , F. Krakowiak , J. Iturra , W. Dorado , R. Aguilera
{"title":"60P Innovative applications of neoantigens in dendritic cell-derived exosome (DEX) therapy and their impact on personalized cancer treatment","authors":"R.E. Gutierrez , F. Gutierrez Castro , I. Rivadeneira , F. Krakowiak , J. Iturra , W. Dorado , R. Aguilera","doi":"10.1016/j.iotech.2024.100871","DOIUrl":"10.1016/j.iotech.2024.100871","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100871"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
87P Access to vedolizumab for the management of immune-related colitis (IRC): A United Kingdom study vedolizumab用于治疗免疫相关性结肠炎（IRC）：一项英国研究
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100830
F. Coe , M. Deisai , K. Kantilal , J. Parkes , K. Paterson , A. Tew
{"title":"87P Access to vedolizumab for the management of immune-related colitis (IRC): A United Kingdom study","authors":"F. Coe , M. Deisai , K. Kantilal , J. Parkes , K. Paterson , A. Tew","doi":"10.1016/j.iotech.2024.100830","DOIUrl":"10.1016/j.iotech.2024.100830","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100830"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143129138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
54P Superior antitumor activities of fourth-generation CAR-T cells containing three costimulatory domains targeting GD2-positive tumors 含有三个共刺激结构域的第四代CAR-T细胞靶向gd2阳性肿瘤具有卓越的抗肿瘤活性
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100865
J. Sujjitjoon, P. Yuti, K. Kongkla, N. Sawasdee, K. Natungnuy, P-T. Yenchitsomanus
{"title":"54P Superior antitumor activities of fourth-generation CAR-T cells containing three costimulatory domains targeting GD2-positive tumors","authors":"J. Sujjitjoon, P. Yuti, K. Kongkla, N. Sawasdee, K. Natungnuy, P-T. Yenchitsomanus","doi":"10.1016/j.iotech.2024.100865","DOIUrl":"10.1016/j.iotech.2024.100865","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100865"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143130227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
89P Safety and efficacy of rechallenge with immune checkpoint inhibitors in advanced solid tumor: A systematic review and meta-analysis 免疫检查点抑制剂治疗晚期实体瘤的安全性和有效性：系统回顾和荟萃分析
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100832
H.J. Xu
{"title":"89P Safety and efficacy of rechallenge with immune checkpoint inhibitors in advanced solid tumor: A systematic review and meta-analysis","authors":"H.J. Xu","doi":"10.1016/j.iotech.2024.100832","DOIUrl":"10.1016/j.iotech.2024.100832","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100832"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143133457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
62P Ecto-CRT induction of NKp46 surface expression increases osimertinib-resistant lung cancer’s sensitivity to NK cells 62P Ecto-CRT诱导NKp46表面表达增加奥西替尼耐药肺癌对NK细胞的敏感性
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100873
S. Chen , Y. Jounaidi
{"title":"62P Ecto-CRT induction of NKp46 surface expression increases osimertinib-resistant lung cancer’s sensitivity to NK cells","authors":"S. Chen , Y. Jounaidi","doi":"10.1016/j.iotech.2024.100873","DOIUrl":"10.1016/j.iotech.2024.100873","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100873"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143134577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
64P Gene-editing of T cells to provide resistance against macrophage-mediated suppression: Setting up an in vitro model 64P基因编辑T细胞抵抗巨噬细胞介导的抑制：建立体外模型
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100875
R. Coelho , C. Schliehe , E. Shifrut , R. Debets , D. Hammerl
{"title":"64P Gene-editing of T cells to provide resistance against macrophage-mediated suppression: Setting up an in vitro model","authors":"R. Coelho , C. Schliehe , E. Shifrut , R. Debets , D. Hammerl","doi":"10.1016/j.iotech.2024.100875","DOIUrl":"10.1016/j.iotech.2024.100875","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100875"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143134579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
97P Cardiac risk stratification and serial monitoring during immune checkpoint inhibitor therapy: Prospective real-world experience 免疫检查点抑制剂治疗期间心脏风险分层和连续监测：前瞻性现实世界经验
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100840
J. Knott
{"title":"97P Cardiac risk stratification and serial monitoring during immune checkpoint inhibitor therapy: Prospective real-world experience","authors":"J. Knott","doi":"10.1016/j.iotech.2024.100840","DOIUrl":"10.1016/j.iotech.2024.100840","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100840"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
90P Meta-analysis of hypophysitis incidence in melanoma patients treated with immune checkpoint inhibitors 免疫检查点抑制剂治疗黑色素瘤患者垂体炎发病率的meta分析
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100833
V. Urbonas , P. Bernotas , M. Grubliauskaite , D. Dabkeviciene
{"title":"90P Meta-analysis of hypophysitis incidence in melanoma patients treated with immune checkpoint inhibitors","authors":"V. Urbonas , P. Bernotas , M. Grubliauskaite , D. Dabkeviciene","doi":"10.1016/j.iotech.2024.100833","DOIUrl":"10.1016/j.iotech.2024.100833","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100833"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143133458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信